Aaron David Schimmer,Sumaiya Sharmeen,Marko Skrtic
申请号:
US13504578
公开号:
US20120225123A1
申请日:
2010.11.09
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The disclosure relates to a method of treating a hematological malignancy comprising administering to a subject in need thereof a synergistic combination of a first compound comprising an effective amount of one or more Avermectins and a second compound comprising a chemotherapeutic, preferably daunorubicin, cyarabine, doxorubicin, idarubicin mitoxantrone, amsacrine, and mixtures thereof.